Phase II Study of Thalidomide in Mastocytosis.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Thalidomide (Primary)
- Indications Systemic mastocytosis
- Focus Therapeutic Use
Most Recent Events
- 26 Apr 2016 Biomarkers information updated
- 12 May 2011 Actual end date (May 2011) added as reported by ClinicalTrials.gov.
- 12 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.